Guzmán-Vázquez J, Guzmán-Bárcenas J, Ramírez-Mayans J

Language: Spanish
References: 23
Page: 268-273
PDF size: 286.09 Kb.

ABSTRACT

Background: Chronic lung disease (CLD) affects growth, secondary to a greater catabolic process and energy intake and insufficient pulmonary function.
Objective: To analyze the influence of power procedures, content of nutrients and morbidity in postnatal growth during hospital stay.
Material and methods: Cohort of premature 73, very low weight at birth, scanning is the rate of growth (RG) and percentage gain weight with regard to weight birth (PGW). The criterion of income accounted for mechanical ventilation for the two groups and development of CLD for study group. Parenteral nutrition, oral food and medical assistance.
Applied nonparametric descriptive statistics and test for independent samples (body weight, RG and PGW) t. Differences in morbidity and percentages were to observe the influence of the proposed variables. Relative risk on the main factors determined partnership and possible causality.
Results: The velocity of growth in the first week for both groups , was of -15 (± 1.3) and - 11.3 (± 1.3), g/kg/day, week 3: 12.7 (± 1.8) and 18.9 ± 1.9 (p ‹ 0.1) and 4 week with 13.4 ± 0.9 and 18.6 (± 1) (p ‹. 0001). The PGW showed a 5% percentage loss and recovery of weight at birth from the second and third week.
Conclusions: Multiple factors, hospital morbidity and insufficient food schemes promote deterioration in the growth rate and the percentage gain at birth.

REFERENCES

1. Kopelman A, Oommen PM. Common respiratory disorders of the newborn. Pediatrics in Rev 1995;16:209-17.

2. Eber EZ, Zack MS. Long term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy). Thorax 2001;56:317-23.

3. Farrel P, Fiascone J. Bronchopulmonary dysplasia in the 1990s a review for the pediatrician. Curr Probl Pediatr 1997;4:133-63.

4. Cutz E, Chiasson D. Chronic lung disease after premature birth. N Engl J Med 2008;358:743-5.

5. Lai NM, Rajadurai SV, Tan KH. Increased energy intake for preterm infants with (or developing) bronchopulmonary dysplasia/ chronic lung disease. Cochrane Database Syst Rev 2006 Jul 19; CD005093 3.

6. Baumgart S, Costarino A. Water and electrolyte metabolism of the micropremie. Clin Perinatol 2000;27:131-45.

7. Guzmán B, Villalobos A, Cordero G. Enfermedad pulmonar neonatal crónica y velocidad de crecimiento en neonatos con muy bajo peso al nacimiento. Bol Med Hosp Inf Mex 2001;58:455-62.

8. Guzmán BJ, Guzmán VJ. Evaluación del crecimiento postnatal en neonatos de muy bajo peso al nacer con alimentación parenteral hiperproteica. Nutr Clín 2006;9 (3):1-6.

9. Guzmán BJ, Guzmán VJ. Certidumbre en el uso de la nutrición parenteral temprana hiperproteica en neonatos con muy bajo peso al nacer. Nutr Clín 2007;10(3):110–15.

10. Bancalari E, Claure N. Definitions and diagnostic criteria for bronchopulmonary dysplasia. Semin Perinatol 2006;30(4):164–70.

11. Bancalari E. Changes in the pathogenesis and prevention of chronic lung disease of prematurity. Am J Perinatol 2001;18:1-6.

12. Markestad T, Fitzhardinge PM. Growth and development in children recovering from bronchopulmonary dysplasia. J Pediatrics 1981;98:597-602.

13. Davidson S, Schrayer A, Wielunsky E, Krikler R. Energy intake, growth, and development in ventilated very low birth weight with and without bronchopulmonary dysplasia. AJDC 1990;144:553-9.

14. Akram Khan M, Kuzma-O’Reilly B, Brodsky NL, Bhandari V.Site-specific characteristics of infants developing bronchopulmonary dysplasia. J Perinatol 2006;26(7):428-35.

15. Vohr B, Bell E, William O. Infants with bronchopulmonary dysplasia. Am J Dis Child 1982;136:443-7.

16. Kurzner SI, Garg M, Bautista DB, et al. Growth failure in bronchopulmonary dysplasia: elevated metabolic rates and pulmonary mechanics. J Pediatr 1988;112:73-80.

17. Guzmán J, Peralta O. Displasia broncopulmonar, prematurez. Un enfoque perinatal. México. DF: Editores de Textos Mexicanos SA de CV; 2004. p. 363–88.

18. Doyle LW, Anderson PJ. Long-term outcomes of bronchopulmonary dysplasia. Semin Fetal Neonatal Med 2009;14(6):391-5.

19. Coalson JJ. Pathology of new bronchopulmonary dysplasia. Semin Perinatol 2006;30(4):179–84.

20. Casey PH. Growth of low birth weight preterm children. Semin Perinatol 2008;32(1):20-7.

21. Tin W, Wiswell TE. Drug therapies in bronchopulmonary dysplasia: debunking the myths. Semin Fetal Neonatal Med 2009;14(6):383-90.

22. Olsen IE, Richardson DK, Schmid CH, Ausman LM, Dwyer JT. Intersite differences in weight. Velocity growth of extremely premature infants. Pediatrics 2002;110 (6):1125-32.

23. Halliday HL, Ehrenkranz RA, Doyle LW. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2010;(1):CD001146.